Aclaris Therapeutics, Inc. (ACRS)
5.255
-0.25
(-4.54%)
USD |
NASDAQ |
Sep 11, 12:56
Aclaris Therapeutics Gross Profit (TTM) : 1.06M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.06M |
| March 31, 2026 | 0.811M |
| December 31, 2025 | 0.542M |
| September 30, 2025 | 0.626M |
| June 30, 2025 | 1.714M |
| March 31, 2025 | 2.644M |
| December 31, 2024 | 3.263M |
| September 30, 2024 | 14.50M |
| June 30, 2024 | 20.99M |
| March 31, 2024 | 20.96M |
| December 31, 2023 | 22.12M |
| September 30, 2023 | 17.22M |
| June 30, 2023 | 26.88M |
| March 31, 2023 | 26.51M |
| December 31, 2022 | 25.09M |
| September 30, 2022 | 19.20M |
| June 30, 2022 | 1.67M |
| March 31, 2022 | 1.771M |
| December 31, 2021 | 2.048M |
| September 30, 2021 | 1.99M |
| June 30, 2021 | 1.69M |
| March 31, 2021 | 1.786M |
| Date | Value |
|---|---|
| December 31, 2020 | 1.349M |
| September 30, 2020 | 1.122M |
| June 30, 2020 | 1.019M |
| March 31, 2020 | 0.254M |
| December 31, 2019 | -2.054M |
| September 30, 2019 | -1.615M |
| June 30, 2019 | -1.721M |
| March 31, 2019 | 0.882M |
| December 31, 2018 | 3.203M |
| September 30, 2018 | 2.942M |
| June 30, 2018 | 3.122M |
| March 31, 2018 | 0.572M |
| December 31, 2017 | 0.371M |
| September 30, 2017 | 0.086M |
| June 30, 2017 | -0.177M |
| March 31, 2017 | -0.149M |
| December 31, 2016 | -0.12M |
| September 30, 2016 | -0.113M |
| June 30, 2016 | -0.113M |
| March 31, 2016 | -0.086M |
| December 31, 2015 | -0.065M |
| September 30, 2015 | -0.032M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 816.73M |
| Nektar Therapeutics | 53.90M |
| Xeris Biopharma Holdings, Inc. | 279.54M |
| Crinetics Pharmaceuticals, Inc. | 36.49M |
| Alumis, Inc. | 3.87M |